Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Palmo-Plantar Pustular Psoriasis and Pustulosis
NCT01091051Phase 3Terminated
- Sponsor
- Innovaderm Research
- Start
- Mar 2010
- Primary completion
- Aug 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ustekinumab in Palmoplantar Pustular Psoriasis (PPPP), palmoplantar pustulosis (PPP), sponsored by Innovaderm Research. Started Mar 2010; status: terminated.
02
Drugs
ustekinumab
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)palmoplantar pustulosis (PPP)
Beyond the preview
Go deeper on NCT01091051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091051.